Florida
12
3
4
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
75%
3 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury
Role: collaborator
Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System
Role: collaborator
Comparison of Quality and Quantity of M-PRP Cellular Content Filgrastim vs. Pegfilgrastim
Role: collaborator
Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)
Role: collaborator
Effects of Bodily Illusion and tDCS on SCI-related Neuropathic Pain
Role: collaborator
Straight Leg Raise Continuation
Role: collaborator
Evaluation of the Safety and Efficacy of Meniscal Preservation Surgery
Role: collaborator
Addressing Colorectal Cancer in South Florida Firefighters
Role: collaborator
Augmentation of Anterior Cruciate Ligament Reconstruction Using Mesenchymal Stem Cells and Collagen Matrix Carrier
Role: collaborator
Andrews Return to Sport ACL Score
Role: collaborator
Cellular Content of Bone Marrow Aspiration, Comparison
Role: collaborator
Comparison of Proliferative Potential of H-PBSC Based on Demographics and Cryopreservation Time
Role: collaborator
All 12 trials loaded